Vesole DH - Search Results

1

Melphalan-associated pulmonary toxicity following high-dose therapy with autologous hematopoietic stem cell transplantation.

Akasheh MS, Freytes CO, Vesole DH. Akasheh MS, et al. Among authors: vesole dh. Bone Marrow Transplant. 2000 Nov;26(10):1107-9. doi: 10.1038/sj.bmt.1702664. Bone Marrow Transplant. 2000. PMID: 11108311

2

Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy.

Tricot G, Jagannath S, Vesole DH, Crowley J, Barlogie B. Tricot G, et al. Among authors: vesole dh. Bone Marrow Transplant. 1995 Jul;16(1):7-11. Bone Marrow Transplant. 1995. PMID: 7581132

3

Feasibility and cost-effectiveness of outpatient autotransplants in multiple myeloma.

Jagannath S, Vesole DH, Zhang M, Desikan KR, Copeland N, Jagannath M, Bracy D, Jones R, Crowley J, Tricot G, Barlogie B. Jagannath S, et al. Among authors: vesole dh. Bone Marrow Transplant. 1997 Sep;20(6):445-50. doi: 10.1038/sj.bmt.1700900. Bone Marrow Transplant. 1997. PMID: 9313876

4

Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.

Tricot G, Alberts DS, Johnson C, Roe DJ, Dorr RT, Bracy D, Vesole DH, Jagannath S, Meyers R, Barlogie B. Tricot G, et al. Among authors: vesole dh. Clin Cancer Res. 1996 Jun;2(6):947-52. Clin Cancer Res. 1996. PMID: 9816255

5

Bone marrow and stem cell transplantation for multiple myeloma.

Vesole DH. Vesole DH. Cancer Treat Res. 1999;99:171-94. doi: 10.1007/978-0-585-38571-6_7. Cancer Treat Res. 1999. PMID: 9891867 Review. No abstract available.

6

Accelerated atherosclerosis in a patient with post-BMT nephropathy.

Akasheh M, Priyanath A, Pello N, Watry P, Vesole D. Akasheh M, et al. Bone Marrow Transplant. 1999 Jan;23(2):199. doi: 10.1038/sj.bmt.1701544. Bone Marrow Transplant. 1999. PMID: 10197810 No abstract available.

7

Acute tumour lysis syndrome: a case in AL amyloidosis.

Akasheh MS, Chang CP, Vesole DH. Akasheh MS, et al. Among authors: vesole dh. Br J Haematol. 1999 Nov;107(2):387. doi: 10.1046/j.1365-2141.1999.01719.x. Br J Haematol. 1999. PMID: 10583230

8

Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone.

Desikan KR, Tricot G, Dhodapkar M, Fassas A, Siegel D, Vesole DH, Jagannath S, Singhal S, Mehta J, Spoon D, Anaissie E, Barlogie B, Munshi N. Desikan KR, et al. Among authors: vesole dh. Bone Marrow Transplant. 2000 Mar;25(5):483-7. doi: 10.1038/sj.bmt.1702167. Bone Marrow Transplant. 2000. PMID: 10713623 Clinical Trial.

9

Cunninghamella infection post bone marrow transplant: case report and review of the literature.

Darrisaw L, Hanson G, Vesole DH, Kehl SC. Darrisaw L, et al. Among authors: vesole dh. Bone Marrow Transplant. 2000 Jun;25(11):1213-6. doi: 10.1038/sj.bmt.1702395. Bone Marrow Transplant. 2000. PMID: 10849536 Review.

10

Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34(+) cell dose.

Keever-Taylor CA, Klein JP, Eastwood D, Bredeson C, Margolis DA, Burns WH, Vesole DH. Keever-Taylor CA, et al. Among authors: vesole dh. Bone Marrow Transplant. 2001 Apr;27(8):791-800. doi: 10.1038/sj.bmt.1702872. Bone Marrow Transplant. 2001. PMID: 11477435

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

216 results

Search Page

Filters